Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.

scientific article published on 14 July 2016

Possible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/BJD.14864
P698PubMed publication ID27411503

P2093author name stringY Kambayashi
T Fujimura
T Hidaka
S Aiba
S Furudate
A Kakizaki
P2860cites workA homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionQ24336057
RANK is essential for osteoclast and lymph node developmentQ24598872
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLQ24682139
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisQ28589430
Osteoclast differentiation and activationQ29547556
Mammary and extramammary Paget's disease.Q33924372
Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated MacrophagesQ36118028
TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factorQ36380989
Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical InvestigationQ36765862
RANKL inhibition: a promising novel strategy for breast cancer treatment.Q37865171
Targeting RANKL in breast cancer: bone metastasis and beyondQ38081245
RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cellsQ43505096
Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depthQ45376095
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.Q53289573
Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages.Q53475860
The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages.Q54161562
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cellsQ57184743
Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late RelapseQ58211903
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)387-394
P577publication date2016-07-14
P1433published inBritish Journal of DermatologyQ4970191
P1476titlePossible mechanisms of the crosstalk between Langerhans cells and regulatory T cells in extramammary Paget disease by receptor activator of nuclear factor kappa B (RANK) ligand/RANK pathways.
P478volume176

Reverse relations

cites work (P2860)
Q61447969CD30-Positive Angioinvasive Lymphomatoid Papulosis (Type E) Developing from Parapsoriasis en Plaque
Q47109271Langerhans Cells-Programmed by the Epidermis.
Q52674779Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.
Q37634857Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab

Search more.